Adrenocortical suppression after high doses of inhaled fluticasone;Insuficiencia suprarrenal secundaria a dosis altas de fluticasona inhalada

Anales Espanoles de Pediatria

Volumn 52, Issue 5, 2000, Pages 476-478

  Garci Garcia E ^a   Lopez Siguer J P ^a   Perez Frias J ^a   Perez Ruiz E ^a   Martinez Valverde A ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID RECEPTOR; CORTICOTROPIN; FLUTICASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PREDNISONE;

ACID BASE BALANCE; ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ARTICLE; BRONCHUS HYPERREACTIVITY; CORTICOSTEROID THERAPY; DRUG ACTIVITY; DRUG DEGRADATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; METERED DOSE INHALER; VOMITING;

ADMINISTRATION, INHALATION; ADRENAL INSUFFICIENCY; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; HUMANS; INFANT; MALE;

EID: 0034447672     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Relative safety and efficacy of inhaled corticosteroids
2. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children
3. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children
4. Measures of systemic activity of inhaled glucocorticoid in children: A comparison of urine cortisol excretion and knemometry
5. Adrenal cortex function in children with bronchial asthma in fluticasone therapy
6. Adrenal function and high dose inhaled corticosteroids for asthma
7. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
8. A placebo controlled trial of fluticasone propionate in asthmatic children
9. Clinical experience with fluticasone propionate in asthma: A meta-analysis of efficacy and systemic activity compared with budesonide and beclometasone dipropionate at half the micrograme dose or less
10. Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage of 400 mcg/day
11. A randomized, double-blind dose reduction study to compare the minimal effective close of budesonide Turbuhaler and fluticasone propionate Diskhaler (clinical aspects of allergic disease)
12. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 microg/day with inhaled beclomethasone dipropionate 400 microg/day in mild and moderate asthma
13. Growth in asthmatic children treated with fluticasone propionate
14. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma
15. Efficacy and safety of high-dose inhaled steroids in children with asthma: A comparison of fluticasone propionate with budesonide
16. Bone, growth and collagen markers in children treated with fluticasone propionate and budesonide
17. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate
18. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate
19. Pituitary adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment
20. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis
21. Phannacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects
22. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor